| Authors: |
Morgan ET; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia (E.T.M.); Research, Shriners Hospitals for Children International, Tampa, Florida (R.F.N.); Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona (J.R.H.); Department of Molecular Medicine, Scripps Research, La Jolla, California (E.F.J.); and Pfizer Research and Development, Andover, Massachusetts (J.C.S.) etmorga@emory.edu., Novak RF; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia (E.T.M.); Research, Shriners Hospitals for Children International, Tampa, Florida (R.F.N.); Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona (J.R.H.); Department of Molecular Medicine, Scripps Research, La Jolla, California (E.F.J.); and Pfizer Research and Development, Andover, Massachusetts (J.C.S.)., Halpert JR; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia (E.T.M.); Research, Shriners Hospitals for Children International, Tampa, Florida (R.F.N.); Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona (J.R.H.); Department of Molecular Medicine, Scripps Research, La Jolla, California (E.F.J.); and Pfizer Research and Development, Andover, Massachusetts (J.C.S.)., Johnson EF; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia (E.T.M.); Research, Shriners Hospitals for Children International, Tampa, Florida (R.F.N.); Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona (J.R.H.); Department of Molecular Medicine, Scripps Research, La Jolla, California (E.F.J.); and Pfizer Research and Development, Andover, Massachusetts (J.C.S.)., Stevens JC; Department of Pharmacology and Chemical Biology, Emory University School of Medicine, Atlanta, Georgia (E.T.M.); Research, Shriners Hospitals for Children International, Tampa, Florida (R.F.N.); Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona (J.R.H.); Department of Molecular Medicine, Scripps Research, La Jolla, California (E.F.J.); and Pfizer Research and Development, Andover, Massachusetts (J.C.S.). |
